Form 4: Hims & Hers Health COO Melissa Baird Exercises Options and Sells Shares
SEC Form 4 Filing
Chief Operating Officer of Hims & Hers Health, Melissa Baird, exercised stock options and sold shares of Class A Common Stock on May 12, 2025, according to a Form 4 filing with the SEC.
Summary
- Melissa Baird, the Chief Operating Officer of Hims & Hers Health, Inc., executed a transaction involving the company's stock on May 12, 2025.
- Baird exercised stock options to acquire 33,333 shares of Class A Common Stock at a price of $2.43 per share.
- Simultaneously, Baird sold a total of 33,333 shares of Class A Common Stock in multiple transactions at varying prices ranging from $54.9786 to $57.8728.
- These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on November 26, 2024.
- Following these transactions, Baird directly owns 805,083 shares of Class A Common Stock and 693,795 derivative securities (stock options).
Sentiment
Score: 5
Explanation: The sentiment is neutral. It's a routine filing related to stock option exercises and sales under a pre-arranged plan. There's no indication of unusual or concerning activity.
Positives
- The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, which can mitigate concerns about insider trading.
Risks
- Executive stock sales can sometimes be perceived negatively by investors, although the existence of a 10b5-1 plan mitigates this concern.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies. Monitoring these transactions can provide insights into management's perspective on the company's valuation and future prospects.
Stakeholder Impact
- The stock sale could have a minor impact on shareholders due to the increased supply of shares in the market, but the effect is likely minimal given the relatively small number of shares involved and the existence of a 10b5-1 plan.
Key Dates
| Date | Description |
|---|---|
| 2021 | Company's business combination transaction; option converted into the right to purchase 779,073 shares of the Company with an exercise price of $1.75. |
| 11/26/2024 | Date the Rule 10b5-1 trading plan was adopted by the Reporting Person. |
| 05/12/2025 | Date of the stock option exercise and sale of shares. |
| 05/13/2025 | Date of signature on the Form 4 filing. |
| 05/13/2030 | Expiration date of the stock options. |
Keywords
Form 4, Hims & Hers Health, Melissa Baird, stock options, Class A Common Stock, Rule 10b5-1, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.